Market Research Industry Today

Emerging Trends and Innovations for the AI in Clinical Trials Market | projected to reach USD 6.55 Billion by 2030

AI in Clinical Trials Market was valued USD 1.59 Billion in 2023 and projected to reach USD 6.55 Billion by 2030, growing at a CAGR of 22.4 % during the forecast period of 2023-2030 - published by MarketDigits
Published 28 November 2024

According to a research report "AI in Clinical Trials Market, By Offering (Software {Phase I, Phase II, Phase III}, Services {Phase I, Phase II, Phase III}) Technology (Deep Learning, Machine Learning, Other Machine Learning Technologies, Supervised Learning, Others), Application (Cardiovascular diseases, Immunology disease, Infecstious disease, Metabolic diseases, Nuerological disease and condition, Oncology, Others), End User (Contract research organizations, Pharmaceutical & biotechnology companies, Others) & Region - Global Forecast to 2030.

AI in Clinical Trials Market was valued USD 1.59 Billion in 2023 and projected to reach USD 6.55 Billion by 2030, growing at a CAGR of 22.4 % during the forecast period of 2023-2030.

Download Sample Pages - https://www.marketdigits.com/request/sample/3813

Browse in-depth TOC on AI in Clinical Trials Market

  • 324 - Tables
  • 56 - Figures
  • 370 - Pages

Market Overview: The AI in Clinical Trials Market is experiencing significant growth as artificial intelligence technologies increasingly integrate into the healthcare and pharmaceutical sectors. Leveraging machine learning algorithms, natural language processing, and data analytics, AI is revolutionizing clinical trial processes by expediting patient recruitment, optimizing trial design, and enhancing data management and analysis. The implementation of AI in clinical trials is streamlining decision-making, reducing costs, and improving overall efficiency, thereby accelerating drug development timelines. The market is witnessing a surge in collaborations between pharmaceutical companies and AI solution providers, fostering innovation in trial methodologies and personalized medicine approaches. Despite regulatory challenges and data privacy concerns, the AI in Clinical Trials Market is poised for continued expansion as stakeholders recognize the transformative potential of these technologies in advancing healthcare research and development.

Market Dynamics

Drivers:

  • Growing Demand for Personalized Medicine.
  • The increasing prevalence of chronic diseases
  • The rise of big data and cloud computing

Opportunities:

  • Integration with other technologies
  • Development of explainable AI models

North America dominates the market for AI in Clinical Trials.

North America exhibits dominant influence in the AI in clinical trials market. The region's leadership is attributed to several factors, including a robust healthcare infrastructure, significant investments in research and development, and the presence of leading pharmaceutical and biotech companies. Moreover, the regulatory environment in North America is conducive to the adoption of innovative technologies, providing a favorable landscape for AI integration in clinical trials. The region benefits from a wealth of data sources and collaborations between technology firms and healthcare institutions, facilitating the development and implementation of AI solutions. The emphasis on precision medicine and personalized healthcare further propels the demand for AI in clinical trials, positioning North America at the forefront of advancements in this rapidly evolving field.

Top Key Players covered in the market report:

  • IBM Corporation
  • Exscientia
  • Saama Technologies
  • Unlearn.AI, Inc.
  • BioSymetrics
  • Euretos
  • Trials.Ai
  • Insilico Medicine
  • Ardigen
  • Pharmaseal
  • Koninklijke Philips N.V.
  • Intel
  • Numerate
  • AiCure
  • LLC
  • Envisagenics
  • NURITAs
  • BioAge Labs, Inc.
  • Symphony AI.
  • Median Technologies
  • Innoplexus
  • Antidote Technologies, Inc.
  • GNS Healthcare
  • Koneksa Health
  • Halo Health Systems
  • DEEP LENS AI.

More for Information - Inquire Now!

Segmentations Analysis of AI in Clinical Trials Market: -

  • By Offering
  • By Technology
  • By Application
  • By End User
  • By Region

About us:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

Contact Us: Email: sales@marketdigits.com

Other Industry News

Ready to start publishing

Sign Up today!